AR and pachyonychia congenita: The reason is that the AR-siRNA delivered into PCs could inhibit the expression of AR protein, thereby interfering with AR-dependent gene expression and inhibiting the proliferation and metastasis of PC cells, rather than directly inhibiting or killing tumor cells [28,29].